Comparison of immunodeficiency and AIDS defining conditions in HIV negative and HIV positive men with haemophilia A.
OBJECTIVE
To investigate the hypothesis that high usage of clotting factor concentrate, rather than HIV infection, is the cause of immunodeficiency and AIDS in men with haemophilia.


METHODS
A comparison of AIDS defining conditions and CD4 counts in HIV positive and HIV negative patients with haemophilia matched for usage of clotting factor concentrate.


METHODS
A comprehensive care haemophilia centre.


METHODS
17 HIV positive and 17 HIV negative male patients with haemophilia A (age range 12-60 at beginning of study period) who had received similar amounts of clotting factor concentrate yearly over the years 1980-90.


METHODS
Clinical events listed as AIDS defining in the Centers for Disease Control AIDS definition; CD4 lymphocyte counts; death.


RESULTS
Of 108 HIV positive male patients with haemophilia A, only 17 could be matched to an HIV negative patient. This was due to the much higher average usage of factor VIII in the HIV positive group. Between 1980 and 1990, 16 clinical events occurred in nine of the 17 HIV positive patients. No event occurred in the 17 HIV negative patients. In each pair the mean CD4 count during follow up was, on average, 0.5 x 10(9)/l lower in the HIV positive patient.


CONCLUSIONS
These data reject the hypothesis that high usage of clotting factor concentrate, rather than HIV infection, is the cause of immunodeficiency and AIDS in men with haemophilia.
Sabin
C A
CA
Department of Public Health, Royal Free Hospital School of Medicine, London.
Pasi
K J
KJ
Phillips
A N
AN
Lilley
P
P
Bofill
M
M
Lee
C A
CA
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy / Q000209:etiology; D000293:Adolescent; D000328:Adult; D018791:CD4 Lymphocyte Count; D005169:Factor VIII / Q000009:adverse effects / Q000627:therapeutic use*; D018023:HIV Seronegativity; D006679:HIV Seropositivity; D006467:Hemophilia A / Q000150:complications* / Q000628:therapy; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D015215:Zidovudine / Q000009:adverse effects / Q000627:therapeutic use
D015215:Zidovudine; D005169:Factor VIII